Avexis, Inc
Novartis Gene Therapies (formerly AveXis) is reimagining medicine to transform the lives of people living with rare genetic diseases. Utilizing cutting-edge technology, we are working to turn promising gene therapies into proven treatments, beginning with our transformative gene therapy for spinal muscular atrophy (SMA). Follow us on LinkedIn: How to reach us: Novartis Gene Therapies 2275 Half Day Road, Suite 200 Bannockburn, IL 60015 Email: gtx.communications@novartis.com Office Phone: 847.572.8280 Toll-free Phone: 844.428.3947
7-day free trial · no credit card
Verified contacts
12
available on Kipplo
LinkedIn employees
105
1001 to 5000 range
Open roles
—
no listings
Distinct roles
12
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 12 verified contacts at Avexis, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
12 contacts with verified email or phone · masked until revealed.
- IH
Ina Hammond
Principal Engineer · Engineering
EmailPhone - JG
Jim Goff
Vice President, Investor Relations and Corporate Communications · Finance & Accounting
EmailPhone - MH
Matthew Haugan
Manager, Manufacturing Support · Manufacturing & Production
EmailPhone - SP
Sravanthi Peruri
Global Qa Documentation Specialist · Other
EmailPhone
Showing 4 of 12 verified contacts
Top roles at Avexis, Inc
12 distinct titles indexed · top 10 shown.
- 1advocacy associate
- 1buyer
- 1global qa documentation specialist
- 1gmp cleaning tech
- 1manager, manufacturing support
- 1master consultant
- 1principal engineer
- 1principal medical writer
- 1senior clinical research associate
- 1sr validation engineer - cw
- +2more titles
Sign up to unlock all 12 contacts at Avexis, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 12 verified contacts at Avexis, Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.